Clinical Trial Update: Contrast Enhanced Endoscopic Ultrasound for Vascular Involvement in Pancreatic Lesions [NA]

View source ↗

Summary

A clinical trial evaluating contrast-enhanced endoscopic ultrasound to assess vascular involvement in pancreatic cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: University of Vermont | Conditions: Pancreatic Tumors | NA | Status: WITHDRAWN